ArticleCurrent medicinal chemistry2026
Identification of Diagnostic Biomarkers Related to Oxidative Stress in Rheumatoid Arthritis.
Article in Current medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to identify oxidative stress-related genes as potential diagnostic biomarkers for rheumatoid arthritis (RA).
methodsWe first obtained RA transcriptomic data from the Gene Expression Omnibus (GEO) database and calculated oxidative stress scores using single-sample gene set enrichment analysis (ssGSEA). Differentially expressed genes (DEGs) were identified by limma (R). Gene Ontology (GO) enrichment was performed using the clusterProfiler package, and weighted gene co-expression network analysis (WGCNA) was used to classify oxidative stress modules. Candidate biomarker genes for RA were screened by support vector machine-recursive feature elimination (SVM-RFE), least absolute shrinkage and selection operator (LASSO), random forest, and eXtreme Gradient Boosting (XGBoost). We then constructed a logistic regression-based diagnostic model. Immune infiltration analysis, pathway enrichment analysis, single-cell RNA sequencing, and in vitro experiments were employed to comprehensively elucidate the expression profiles of the identified genes in rheumatoid arthritis (RA).
resultsRA samples had higher oxidative stress scores than normal samples. WGCNA showed that the cyan module was linked to oxidative stress, from which 88 potential genes were screened. Five signature genes (CARS2, VCP, FCGR2A, ITGB2, SETD2) were selected. RT-qPCR showed higher expression of the five genes in MH7A cells than in HFLS cells. The logistic model developed based on these genes demonstrated robust performance, with an area under the curve (AUC) greater than 0.9 in both training and validation sets. The model was positively associated with ImmuneScore and the infiltration of specific immune cells. Notably, the model genes showed distinct expression patterns in plasmacytoid dendritic cells (pDCs) and monocytes. DISCUSSION: The five oxidative stress-related genes identified in this study exhibited elevated expression in RA. Immune infiltration and pathway enrichment analysis revealed their potential contribution to immune dysregulation via IL6-JAK-STAT3, ROS, and hypoxia pathways in RA.
conclusionThis study established a five-oxidative-stress-gene diagnostic model, offering a potential molecular tool for early RA detection and immune-based patient stratification.
Indexed as
Identifiers
42367122What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.